Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.370
-0.030 (-2.14%)
At close: Apr 28, 2026, 4:00 PM EDT
1.410
+0.040 (2.92%)
Pre-market: Apr 29, 2026, 4:06 AM EDT
Cardiol Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -33.82 | -36.68 | -28.13 | -30.93 | -31.64 | |
| Depreciation & Amortization | 0.1 | 0.37 | 0.25 | 0.22 | 0.22 | |
| Asset Writedown & Restructuring Costs | - | - | - | 1.36 | 0.08 | |
| Stock-Based Compensation | 10.7 | 14.28 | 4.17 | 5.54 | 12.61 | |
| Other Operating Activities | -0.11 | -2.1 | -0.93 | -9.15 | -4.89 | |
| Change in Accounts Receivable | 0.04 | 0.04 | 0.07 | -0.14 | -0.06 | |
| Change in Inventory | - | - | - | - | 0.02 | |
| Change in Accounts Payable | 0.26 | -1.06 | -1.29 | 4.47 | 2.39 | |
| Change in Other Net Operating Assets | -1.04 | 0.09 | 0.68 | 1.42 | -2.27 | |
| Operating Cash Flow | -23.85 | -25.06 | -25.18 | -27.22 | -23.54 | |
| Capital Expenditures | -0.02 | -0.02 | -0.06 | -0.07 | -0.01 | |
| Investing Cash Flow | -0.02 | -0.02 | -0.06 | -0.07 | -0.01 | |
| Long-Term Debt Repaid | -0.06 | -0.04 | -0.06 | -0.05 | -0.05 | |
| Net Debt Issued (Repaid) | -0.06 | -0.04 | -0.06 | -0.05 | -0.05 | |
| Issuance of Common Stock | 16.07 | 21.53 | - | - | 98.72 | |
| Other Financing Activities | -0.48 | -2.65 | - | - | -5.23 | |
| Financing Cash Flow | 15.54 | 18.84 | -0.06 | -0.05 | 93.44 | |
| Foreign Exchange Rate Adjustments | -0.82 | 1.89 | 0.76 | 2.92 | -0.01 | |
| Net Cash Flow | -9.16 | -4.35 | -24.54 | -24.43 | 69.87 | |
| Free Cash Flow | -23.88 | -25.08 | -25.24 | -27.3 | -23.55 | |
| Free Cash Flow Margin | - | - | - | - | -29904.22% | |
| Free Cash Flow Per Share | -0.28 | -0.35 | -0.39 | -0.44 | -0.55 | |
| Levered Free Cash Flow | -13.03 | -11.71 | -14.99 | -20.64 | -4.61 | |
| Unlevered Free Cash Flow | -13.03 | -11.71 | -14.99 | -20.64 | -4.61 | |
| Change in Working Capital | -0.73 | -0.93 | -0.55 | 5.75 | 0.08 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.